What is the Warfarin/Aspirin Study in Heart Failure (WASH)?
The Warfarin/Aspirin Study in Heart Failure (WASH) is a randomized trial conducted in 2004 that compared antithrombotic strategies for patients with heart failure. The study was conducted by Cleland JG, Findlay I, Jafri S, Sutton G, Falk R, Bulpitt C, Prentice C, Ford I, Trainer A, and Poole-Wilson PA and published in the American Heart Journal in 2004. The results of the study showed that warfarin was more effective than aspirin at reducing the risk of death from cardiovascular causes in patients with heart failure. 